Shows & Panels
- The 2014 Big Picture on Cyber Security
- AFCEA Answers
- Ask the CIO
- Connected Government: How to Build and Procure Network Services for the Future
- Continuing Diagnostics and Mitigation: Discussion of Progress and Next Steps
- Federal Executive Forum
- Federal Tech Talk
- The Intersection: Where Technology Meets Transformation
- Maximizing ROI Through Data Center Consolidation
- Moving to the Cloud. What's the best approach for me
- Navigating Tough Choices in Government Cloud Computing
- The New Generation of Database
- Satellite Communications: Acquiring SATCOM in Tight Times
- Transformative Technology: Desktop Virtualization in Government
- Value of Health IT
Shows & Panels
News Summary: Pfizer disputes lawsuit over Zoloft
Thursday - 1/31/2013, 5:33pm EST
(AP) - RARE CASE: A federal lawsuit claims popular antidepressant Zoloft has no more benefit than a dummy pill, so patients who took it should be reimbursed for their costs.
OPPOSING VIEWS: Lawyer Brent Wisner says Zoloft shouldn't have been approved because there wasn't enough evidence it works. Zoloft maker Pfizer and several psychiatry experts say studies and two decades of use by patients show the pill is effective.
COMPLEX SCIENCE: It's hard to exactly measure an antidepressant's value. Most patients need to try a few to find one that works for them, and they help patients with severe depression the most.
(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)